More Americans With Diabetes Are Turning to Marijuana
Medically reviewed by Drugs.com.
By Ernie Mundell HealthDay Reporter
WEDNESDAY, July 24, 2024 -- As marijuana loses much of its stigma and laws around its use relax, Americans are increasingly consuming it medically and recreationally.
Americans with diabetes are no exception, a new study finds.
The number of adults with diabetes who said that they'd used cannabis at least once over the past month jumped by a third between 2021 and 2022, the new report found.
This surge in use means that "clinicians must discuss with their patients with diabetes the potential harms of cannabis use on diabetes-related outcomes," even as the merits of marijuana for diabetes care remain unclear, wrote a team from the University of California, San Diego (UCSD).
The findings were published July 22 in the journal Diabetes Care.
The new study was led by Dr. Benjamin Han, associate chief of research in the Division of Geriatrics, Gerontology and Palliative Care at UCSD.
His team looked at federal data from the 2021-2022 National Survey on Drug Use and Health.
During that time, about 9% of adults with diabetes said they'd used cannabis at least once over the prior month, and the rate rose from 7.7% in 2021 to 10.3% in 2022, a 33.7% rise.
Users tended to be younger: "Nearly half [48.9%] of the people with diabetes who used cannabis were under age 50," the team noted.
Use was nearly three times more likely if people lived in a state where marijuana was legal, and a history of major depression also increased the odds that a person with diabetes would use the drug.
Use of illicit drugs or heavy alcohol use also heightened the odds that a person with diabetes might use cannabis, Han's team found.
That could prove to be a toxic mix for people battling diabetes, the researchers warned.
"In addition to cannabis, use of some substances, including tobacco and excess alcohol use, are established risk factors for cardiovascular disease and could impact glucose metabolism," they explained. "Additionally, cannabis may complicate diabetes management, adversely affecting glycemic control and self-management behaviors."
All of this means that doctors need to ask patients with diabetes about their use of marijuana and other substances.
"Our results emphasize the importance of comprehensive substance use screenings in diabetes care, with a specific focus on cannabis," Han and his colleagues wrote.
Sources
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2024-07-24 23:15
Read more
- Four Million Americans Could Lose Health Coverage Once ACA Credits Expire
- Ordinal Score Predicts Freedom From Epilepsy One Year After Surgery
- Elevar Therapeutics Announces FDA Acceptance of New Drug Application Resubmission for Rivoceranib in Combination with Camrelizumab as a First-line Systemic Treatment for Unresectable Hepatocellular Carcinoma
- Autism Diagnoses Rising Among U.S. Children, Adults
- More Than Four in 10 U.S. Adults Have Fatty Liver Disease
- Merck and Moderna Initiate Phase 3 Trial Evaluating Adjuvant V940 (mRNA-4157) in Combination with Keytruda (pembrolizumab) After Neoadjuvant Keytruda and Chemotherapy in Patients With Certain Types of Non-Small Cell Lung Cancer (NSCLC)
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions